title: A Us Hospital Economic Impact Model for Oritavancin In Absssi Patients With Risk of Mrsa Infections.
authors.affiliation: ICON plc, Cambridge, MA, USA.
authors.forename: C
authors.initials: C
authors.lastname: Wu
authors.affiliation: ICON plc, Cambridge, MA, USA.
authors.forename: K J
authors.initials: KJ
authors.lastname: Fortier
authors.affiliation: The Medicines Company, Parsippany, NJ, USA.
authors.forename: K
authors.initials: K
authors.lastname: LaPensee
authors.affiliation: The Medicines Company, Parsippany, NJ, USA.
authors.forename: W
authors.initials: W
authors.lastname: Fan
authors.affiliation: The Medicines Company, Parsippany, NJ, USA.
authors.forename: M
authors.initials: M
authors.lastname: Mitchell
authors.affiliation: ICON plc, Cambridge, MA, USA.
authors.forename: P L
authors.initials: PL
authors.lastname: Cyr
authors.affiliation: ICON plc, Cambridge, MA, USA.
authors.forename: I S
authors.initials: IS
authors.lastname: Jensen